Patent details

93189 Product Name: Ixekizumab et ses dérivés pharmaceutiquement acceptables (TALTZ)

Basic Information

Publication number:
93189
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP068464643
Legal Status:
Inactive
Application number:
93189
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1085
Marketing Authorization Type:
Marketing Authorization Date:
28/04/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
31/08/2016
First Marketing Authorization date:
28/04/2016
Grant date:
31/10/2016
Activation date:
Publication date:
31/10/2016
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
28/04/2031
SPC Extension Expiration:
28/04/2031
Rejection date:
Withdrawal date:

Owner

From:
31/08/2016
 
 

Name:
ELI LILLY AND COMPANY
Address:
LILLY CORPORATE CENTER, INDIANAPOLIS, INDIANA 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
31/08/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LIU Ling
Address:
United States (US)

2

Name:
NG Kingman
Address:
United States (US)

3

Name:
LU Jirong
Address:
United States (US)

4

Name:
TETREAULT Jonathan, Wendell
Address:
United States (US)

5

Name:
HUANG Lihua
Address:
United States (US)

6

Name:
ALLAN Barrett
Address:
United States (US)

7

Name:
CHOW Chi-kin
Address:
United States (US)

8

Name:
WERNER Andrew, Gordon
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
04/08/2020 Outgoing Correspondence 1
04/08/2020 Incoming Correspondence (Post) 1